124 247

Cited 0 times in

Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo

 Chae Gyu Park 
 Clinical Experimental Vaccine Research, Vol.3(2) : 149-154, 2014 
Journal Title
 Clinical Experimental Vaccine Research 
Issue Date
Antigen receptor ; C-type lectins ; Dendritic cells ; Monoclonal antibody
Dendritic cells (DCs) are professional antigen-presenting cells capable of initiating and regulating innate and adaptive immunity. The development of effective ways to produce a large number of DCs in laboratories made the use of DCs available in various vaccine approaches. Compared to conventional vaccines, focused on protective antibody responses, DC vaccines emphasize protective T cell immunity but might elicit strong antibody responses as well. In addition, the recent discoveries of functionally distinct DC subsets in various organs and tissues are likely to increase the potential of exploiting DCs in vaccines and immunotherapy. Vaccines composed of DCs generated ex vivo, pulsed with antigens, and matured prior to being re-infused to the body have been widely tried clinically but resulted in limited success due to various obstacles. In this review, new approaches that protein vaccines are selectively targeted to the endocytic C-type lectin receptors on surface of DCs in vivo are discussed.
Files in This Item:
T201403006.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > BioMedical Science Institute (의생명과학부) > 1. Journal Papers
Yonsei Authors
Park, Chae Gyu(박채규) ORCID logo https://orcid.org/0000-0003-1906-1308
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.